POTENTIAL PROBLEM IN DIGOXIN THERAPY DUE TO VARIATION IN RECOMMENDED DOSAGE REGIMENS

被引：5

作者：

CHIOU, WL ^{[1
]}

机构：

[1] UNIV ILLINOIS,MED CTR,COLL PHARM & OCCUPAT & ENVIRONM,SCH PUBL HLTH,DEPT PHARM,CHICAGO,IL 60612

来源：

关键词：

D O I：

10.1002/j.1552-4604.1975.tb01448.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：272 / 275

页数：4

共 22 条

[1] PLASMA DIGOXIN CONCENTRATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
CHAMBERLAIN, DA
WHITE, RJ
HOWARD, MR
SMITH, TW
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1970, 3 (5720): : 429 - +
[2] EVERED DC, 1971, BRIT HEART J, V33, P540
[3] MEASUREMENT OF PLASMA DIGOXIN CONCENTRATION BY RADIOIMMUNOASSAY
EVERED, DC
CHAMPMAN, C
HAYTER, CJ
[J]. BRITISH MEDICAL JOURNAL, 1970, 3 (5720) : 427 - &
[4] FLECKENS.L, 1974, CLIN PHARMACOL THER, V16, P435
[5] GOLDSTEIN A, 1974, BASIS PHARM, P311
[6] EVALUATION OF DIGOXIN BIOAVAILABILITY IN SINGLE-DOSE STUDIES
GREENBLATT, DJ
DUHME, DW
KOCHWESE.J
SMITH, TW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (13) : 651 - 654
[7] HUFFMAN DH, 1974, CLIN PHARMACOL THER, V16, P310
[8] HUFFMAN DH, 1972, J AMER MED ASSOC, V222, P957, DOI 10.1001/jama.222.8.957
[9] KARLINEAR JS, 1973, CURRENT THERAPY, P192
[10] KOCHWESE.J, 1974, CLIN PHARMACOL THER, V16, P284